Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142772 |
| CAS No | NA |
| Mol.F. | C14H10Cl2N2O4 |
| Mol.Wt. | 341.14 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142773 |
| CAS No | NA |
| Mol.F. | C21H16Cl2N2O3 |
| Mol.Wt. | 415.27 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142774 |
| CAS No | NA |
| Mol.F. | C18H18Cl2N2O4 |
| Mol.Wt. | 397.25 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142775 |
| CAS No | NA |
| Mol.F. | C20H18Cl2N2O9 |
| Mol.Wt. | 501.27 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142776 |
| CAS No | NA |
| Mol.F. | C23H22Cl2N2O9 |
| Mol.Wt. | 541.33 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142777 |
| CAS No | NA |
| Mol.F. | C28H19Cl4N3O5 |
| Mol.Wt. | 619.28 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142778 |
| CAS No | NA |
| Mol.F. | C26H34Cl2N2O3 |
| Mol.Wt. | 493.47g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142779 |
| CAS No | NA |
| Mol.F. | C24H28Cl2N2O3 |
| Mol.Wt. | 463.40 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142780 |
| CAS No | NA |
| Mol.F. | C32H42Cl2N2O4 |
| Mol.Wt. | 589.60 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142781 |
| CAS No | NA |
| Mol.F. | C35H50Cl2N2O4 |
| Mol.Wt. | 633.70 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142782 |
| CAS No | NA |
| Mol.F. | C14H9ClN2O3 |
| Mol.Wt. | 288.69 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142783 |
| CAS No | NA |
| Mol.F. | C14H10N2O3 |
| Mol.Wt. | 254.25 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142784 |
| CAS No | NA |
| Mol.F. | C17H18ClN3O2 |
| Mol.Wt. | 331.8 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142785 |
| CAS No | NA |
| Mol.F. | C17H18ClN3O2 |
| Mol.Wt. | 331.8 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142786 |
| CAS No | NA |
| Mol.F. | C17H19N3O2 |
| Mol.Wt. | 297.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142787 |
| CAS No | 1254360-38-7 |
| Mol.F. | C6H11N3O2 |
| Mol.Wt. | 157.2 g/mol |
| INV STATUS | In Stock |